Michael Arena
About Michael Arena
Michael Arena is a Regional Account Executive specializing in value, access, and payments at Bristol Myers Squibb in the New York City Metropolitan Area, with over 15 years of experience in the pharmaceutical and biotechnology industries.
Title
Michael Arena currently serves as a Regional Account Executive specializing in Value, Access, and Payments at Bristol Myers Squibb in the New York City Metropolitan Area.
Current Role at Bristol Myers Squibb
Michael Arena is currently employed at Bristol Myers Squibb as a Regional Account Executive focused on Value, Access, and Payments. In this role, he navigates the complexities of healthcare payments and access, aiming to deliver value to both the organization and its customers.
Previous Roles at Bristol Myers Squibb
Before his current role, Michael Arena worked at Bristol Myers Squibb as a Community Product Specialist in Immuno-Oncology from 2017 to 2021. In this position, he focused on product specialization for immuno-oncology treatments, based in Long Island, NY.
Experience at Amgen
Michael Arena accumulated noteworthy experience at Amgen, serving as a District Sales Manager from 2015 to 2017 and as a Senior Biopharmaceutical Representative from 2011 to 2015 in Long Island, NY. These roles bolstered his expertise in sales management and biopharmaceutical products.
Career at Abbott
From 2004 to 2011, Michael Arena held various positions at Abbott, including Senior Sales Representative, Regional/Area Training Specialist, and District Sales Manager. His responsibilities spanned multiple regions such as Manhattan, Brooklyn, Queens, Bronx, Staten Island, and Long Island in NY, as well as Philadelphia, PA, and Chicago, IL. These roles focused on sales and training within the pharmaceutical sector.
Education and Academic Background
Michael Arena earned a Bachelor of Science degree from Cortland State University, where he studied from 1996 to 2000. This educational foundation has supported his over 15-year-long career in the pharmaceutical and biotechnology industries.